Trial Profile
Phase I trial for Gastrointestinal cancer
Planning
Phase of Trial:
Phase I
Latest Information Update: 16 Oct 2018
At a glance
- Drugs RGX-202 (Primary)
- Indications Gastric cancer
- Focus Adverse reactions
- 16 Oct 2018 New trial record
- 09 Oct 2018 According to Rgenix media release, company expects to lauch this study in 2018